Drug
Bempedoic acid clinical trials
Also written ETC-1002 and Nexletol.
- studies test it
- 43
- open now
- 10
- in phase 3
- 13
- first study started
- 2010
Keep track of what changes. Save the bempedoic acid studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
43 studies that test it; most in 2025 (7)
| Year | Studies |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 5 |
| 2017 | 4 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 6 |
| 2024 | 4 |
| 2025 | 7 |
| 2026 | 6 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 8
- Phase 2
- 14
- Phase 3
- 13
- Phase 4
- 6
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 34 · Other 9
Esperion Therapeutics, Inc. (20) · Daiichi Sankyo (6) · Otsuka Pharmaceutical Co., Ltd. (3) · Humanis Saglık Anonim Sirketi (2) · Bahria University (1) · AstraZeneca (1) · CSPC Ouyi Pharmaceutical Co., Ltd. (1) · Punjab Institute of Cardology (1)
Often tested with
Tested in the same studies.
Ezetimibe (11) · Rosuvastatin (4) · Atorvastatin (4) · Laroprovstat (1) · Bempedoic Acid/Ezetimibe (1) · Hydroxymethylglutaryl-CoA Reductase Inhibitors (1) · Evolocumab (1) · Alirocumab (1)
Studies
Open first, then newest update. How each study uses bempedoic acid is read from its arms, and is right about nine times in ten.
Testing it · 43
- A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular EventsNot yet recruitingPhase 3Daiichi SankyoNCT07474649Written as Bempedoic acid
- Bempedoic Acid Therapy for Polycystic Kidney DiseaseRecruitingPhase 2Kenneth HallowsNCT07282821Written as Bempedoic Acid 180 MG Oral Tablet
- Early Triple Lipid-Lowering Therapy With Bempedoic Acid After Acute Coronary SyndromeRecruitingPhase 4Taipei Medical University HospitalNCT07824323Written as bempedoic acid
- A Clinical Study to Evaluate the Efficacy and Safety of Bempedoic AcidNot yet recruitingPhase 3CSPC Ouyi Pharmaceutical Co., Ltd.NCT07623915Written as Bempedoic Acid Tablet
- Triple vs Dual Lipid-Lowering Therapy for LDL-C Reduction in Acute Coronary SyndromeNot yet recruitingPhase 4Punjab Institute of CardologyNCT07508254Written as Bempedoic Acid 180 MG Oral Tablet
- Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)RecruitingPhase 2Priscilla Hsue, MDNCT05488431Written as Bempedoic acid
- Bempedoic Acid Versus Statins in Primary-Prevention Patients With Suboptimal Statin Adherence: Effects on LDL-C Reduction and TolerabilityNot yet recruitingPhase 3Sohaib AshrafNCT07239414Written as Bempedoic Acid 180 MG Oral Tablet
- Effect of Bempedoic Acid on Liver Fat in Individuals With Nonalcoholic Fatty Liver Disease and Type 2 DiabetesRecruitingNot applicableMedanta, The Medicity, IndiaNCT06035874Written as Bempedoic acid
- A Clinical Study to Evaluate the Efficacy, Tolerability, and Safety of Bempedoic AcidRecruitingPhase 3Gan & Lee Pharmaceuticals.NCT06780410Written as Bempedoic Acid Tablet
- Intensive Lipid-lowering in Patients With STEMI and NSTEMI (Germany on Target)Not yet recruitingNot applicableJena University HospitalNCT05587621Written as statins, ezetimibe, bempedoic acid, evolocumab, alirocumab, inclisiran
- Dual vs Triple Lipid-Lowering Therapy in Type 2 Diabetes Mellitus Patients With Elevated LDL CholesterolCompletedPhase 4Bahria UniversityNCT07255820Written as Bempedoic Acid + Ezetimibe
- A Clinical Study in Children With Heterozygous Familial Hypercholesterolemia (HeFH) Aged 6 to 17 Treated Once Daily With Bempedoic Acid Oral Dosing (CLEAR Path 1)CompletedPhase 2Esperion Therapeutics, Inc.NCT05694260Written as Bempedoic acid
- Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid / Ezetimibe, and AtorvastatinCompletedPhase 1Daiichi SankyoNCT07268625Written as Bempedoic acid
- A Long-term Trial of ETC-1002 in Patients With Hyper-LDL CholesterolemiaCompletedPhase 3Otsuka Pharmaceutical Co., Ltd.NCT05687071Written as 180mg of ETC-1002(bempedoic acid)
- A Study Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid, Ezetimibe, and AtorvastatinCompletedPhase 1Daiichi SankyoNCT07235189Written as Bempedoic acid
- Evaluating Bioequivalence of a Fixed Dose Combination Versus Tablets of Bempedoic Acid / Ezetimibe and RosuvastatinCompletedPhase 1Daiichi SankyoNCT07201545Written as Bempedoic acid
- Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid, Ezetimibe, and RosuvastatinCompletedPhase 1Daiichi SankyoNCT07182383Written as Bempedoic acid
- A Study to Investigate the Effectiveness and Safety of Bempedoic Acid in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia in TaiwanCompletedPhase 4Daiichi SankyoNCT06925100Written as Bempedoic acid 180 mg tablet
- A Study to Investigate the Pharmacokinetics, Safety, Tolerability, and Efficacy of AZD0780 With Ezetimibe Combinations in Healthy Adults With Elevated LDL-C.CompletedPhase 1AstraZenecaNCT06742853Written as Bempedoic Acid
- Bioequivalence Study of Bempedoic Acid 180 mg Film Coated Tablet and Nilemdo® (Bempedoic Acid) 180 mg Film-coated TabletsCompletedPhase 1Humanis Saglık Anonim SirketiNCT07170852Written as Bempedoic acid film coated tablet
See all 43 studies that test bempedoic acid →
As the comparator · 1 — what is tested is compared with bempedoic acid
Codes
What other systems call bempedoic acid · ClinicalTrials.gg INT006282
- MeSH (NLM) C5812368-hydroxy-2,2,14,14-tetramethylpentadecanedioic acidConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 1EJ6Z6Q368BEMPEDOIC ACIDConfirmed FDA, NLM, Wikidata
- RxNorm 2282403One source FDA
- Wikidata Q27075007bempedoic acidConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C166494Bempedoic AcidOne source FDA
- DrugBank DB11936One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C581236 | 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 1EJ6Z6Q368 | BEMPEDOIC ACID | Confirmed FDA, NLM, Wikidata |
| RxNorm | 2282403 | — | One source FDA |
| Wikidata | Q27075007 | bempedoic acid | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C166494 | Bempedoic Acid | One source FDA |
| DrugBank | DB11936 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.